Your Article Summary
See Latest ArticlesRituximab treatment of the anti-synthetase syndrome—a retrospective case series
Rheumatology, 06/22/09
Sem M et al. – This retrospective case series indicates a short-term beneficial effect of rituximab in anti-synthetase syndrome (ASS). Prospective, controlled studies are needed to validate this finding and further assess safety issues.
Methods- A retrospective case series to assess ASS pts with interstitial lung disease (ILD) treated with rituximab
- 11 ASS pts; data on clinical and laboratory parameters, lung imaging by high-resolution CT thorax and pulmonary function tests were collected, 6 mo pre-treatment, and 3 and 6 mo post-treatment
- All 11 ASS pts had severe and progressive ILD and most of them had previously failed on cyclophosphamide and/or other immuno-modulating agents
- Rituximab appeared to stabilize and/or improve the ILD in 7/11 ASS pts during the first 6 mo after treatment
- Rituximab treatment appeared to decrease the serum level of anti-Jo-1 Ab, but the decrease was most often modest
- One patient developed a fatal infection 3 mo after the last infusion with rituximab
- In the other ASS pts, the treatment was well tolerated
Related Articles
Treatment of adult inflammatory myositis with rituximab: An emerging therapy for refractory patients
Journal of Clinical Rheumatology (JCR), 10/08/09
Relevance Score: 90%
Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection
Nephrology, 10/07/09
Relevance Score: 89%
Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: Effects of rituximab
Annals of Oncology, 11/10/09
Relevance Score: 88%
Prevention of hepatitis B virus reactivation under rituximab therapy
Immunotherapy, 11/06/09
Relevance Score: 88%
Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy
Annals of Oncology, 11/06/09
Relevance Score: 87%
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of autoinflammation and autoimmunity using TRAPS and rheumatoid arthritis as prototypes of these conditions
International Journal of Clinical Rheumatology, 12/04/09
Telangiectases in scleroderma: A potential clinical marker of pulmonary arterial hypertension
Journal of Rheumatology, 12/03/09
The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome
Rheumatology, 12/01/09